COVID-19 in Belgium
Current COVID-19 activity in Belgium, based on ECDC ERVISS weekly data from Sciensano.
This page tracks how much COVID-19 is circulating, not symptoms or diagnosis.
Influenza: Low
Low
The source currently reports no meaningful activity (as of 16 Aug 2026).
Data window: Week 33 · Aug 10 – Aug 16 · Source: ECDC (weekly) · Source on seasonal break, next data from week 40
Get one free alert when the wave turns in Belgium
We write exactly once: the moment the level goes up. No account, no newsletter. We store your address and the country, nothing else. Every mail has a one click unsubscribe. Privacy
View the last 8 weeks
In week 33 of 2026, Influenza activity in Belgium is classified as low.
The source reports no meaningful activity across these weeks; a week-over-week percentage would be pure noise here.
The last 8 reported weeks
| Week | Relative | Level | vs prior week |
|---|---|---|---|
| Week 33 | – | Low | – |
| Week 32 | – | Low | – |
| Week 31 | – | Low | – |
| Week 30 | – | Low | – |
| Week 29 | – | Low | – |
| Week 28 | – | Low | – |
| Week 27 | – | Low | – |
| Week 26 | – | Low | – |
Across these weeks the source reports no meaningful activity, the values sit at the floor of its scale.
Current activity
- InfluenzaLowstableWeek 33Trend: stable · Week 33
- COVID-19LowstableWeek 33Trend: stable · Week 33
- RSVLowstableWeek 33Trend: stable · Week 33
What this means
In week 33 of 2026, activity of COVID-19 in Belgium is low. The trend, derived from clinical surveillance, is stable.
Data, context and methodology
The current picture for Belgium is built on the European Respiratory Virus Surveillance Summary (ERVISS), published weekly by the European Centre for Disease Prevention and Control (ECDC). Sciensano via its sentinel GP network and the National Reference Centre for Influenza is the national public-health authority that feeds ERVISS with sentinel primary care and virology data.
ECDC ERVISS
ERVISS is ECDC's weekly pan-European surveillance summary for influenza, SARS-CoV-2 and RSV. National authorities, in Belgium's case Sciensano via its sentinel GP network and the National Reference Centre for Influenza, submit harmonised indicators every week, which ECDC publishes in a standardised dataset on Thursdays. Using ERVISS rather than each country's native portal ensures cross-country comparability.
ILI / ARI consultation rates and positivity
Sciensano via its sentinel GP network and the National Reference Centre for Influenza operates a sentinel network of general practices that report weekly rates of patients consulting for influenza-like illness (ILI) or acute respiratory infection (ARI). A subset of patients is swabbed and tested by reference laboratories, producing pathogen-specific positivity rates for flu, SARS-CoV-2 and RSV.
Why this source
Combining consultation incidence with virological positivity yields a pathogen-specific weekly incidence signal (ILI × positivity / 100). This is the standard European methodology and provides a more robust view than either indicator alone: consultation rates capture illness burden, positivity confirms which pathogen is driving it.
Qualitative classification
The “low”, “moderate” and “high” categories follow seasonal reference values and epidemiological thresholds calibrated to match our classifications for other countries. The ILI × positivity / 100 product is scaled to comparable thresholds using a divisor of 3, which aligns European sentinel peaks with the consultation-equivalent scale used elsewhere. Data refreshes weekly when ECDC publishes the latest ERVISS update, typically on Thursdays.
Source and seasonal pattern by pathogen
- Influenza
- The classification is based on the ECDC ERVISS weekly reports, drawing on data from Sciensano via its sentinel GP network and the National Reference Centre for Influenza. Seasonally, infection waves in Belgium typically peak between December and February; activity is usually markedly lower during the summer months.
- COVID-19
- The classification is based on the ECDC ERVISS weekly reports, drawing on COVID-19 surveillance data from Sciensano via its sentinel GP network and the National Reference Centre for Influenza. Seasonally, infection waves in Belgium typically peak during winter, with occasional summer waves driven by new variants; activity is usually markedly lower in late spring between waves.
- RSV
- The classification is based on the ECDC ERVISS weekly reports, drawing on RSV surveillance data from Sciensano via its sentinel GP network and the National Reference Centre for Influenza. Seasonally, infection waves in Belgium typically peak between December and February; activity is usually markedly lower in spring and summer.
Frequently asked questions
How is COVID-19 monitored in Belgium today?
Sciensano integrates COVID-19 into its broader respiratory-virus surveillance. The core indicators are sentinel GP consultations, sentinel-laboratory positivity, hospital and ICU admissions for severe acute respiratory infection, wastewater detection of SARS-CoV-2, and variant characterisation at the National Reference Centre. Weekly results are published openly and reported to ECDC ERVISS.
Is COVID-19 still a concern in Belgium?
COVID-19 is endemic in Belgium and continues to cause hospital admissions each winter, concentrated in older adults and people with weakened immune systems. Vaccination and prior infection mean most healthy adults experience a milder illness than in earlier pandemic years. Sciensano monitors the weekly picture and publishes updated advice from the Conseil Supérieur de la Santé / Hoge Gezondheidsraad on booster eligibility.
When do COVID-19 waves happen in Belgium?
COVID-19 in Belgium has not settled into a strict single-season rhythm. Autumn and winter waves overlapping with flu and RSV are the most consistent pattern, but spring or summer upticks can occur when new immune-escape variants emerge. Rising wastewater signals and hospital admissions are typically Sciensano's earliest indicators of a shift from baseline to elevated activity.
Who is eligible for a COVID-19 booster in Belgium?
Belgian autumn booster campaigns target groups advised by the Conseil Supérieur de la Santé / Hoge Gezondheidsraad, typically including adults aged 65 and above, pregnant women, people with chronic conditions, residents of long-term-care facilities, and healthcare workers. Vaccines are available through GPs, pharmacies, and regional vaccination points. Sciensano reports uptake alongside weekly virological surveillance.
Are new variants still tracked in Belgium?
Yes. Belgian laboratories and the National Reference Centre at Sciensano continue to sequence SARS-CoV-2 samples from sentinel surveillance and hospital cases. Most emerging lineages cause illness similar to their predecessors, but variants with notable immune escape can drive faster waves. Belgian variant trends are reported weekly and feed into the ECDC ERVISS platform for Europe-wide context.
More situation reports
Data last refreshed: Aug 31, 2026, 11:10. Update cadence: weekly.
This page is not medical advice and does not replace consultation with a healthcare professional. For specific symptoms, please contact a medical professional.
About this page
Published by Renderei Martin GmbH, Berlin. No commercial interest in individual health recommendations. The app is optionally monetised via a freemium subscription.
Content is based exclusively on the linked official surveillance publications. Medical statements are curated against the guidance of RKI, ECDC and WHO.
Methodology enquiries: press@infectrisk.com